BIO 2026: What to know about the AI Summit
“AI systems will likely have a central role over the next several years in almost every component of the biotech ecosystem,” says Joe Franklin, […]
BIO 2026: What to know about the AI Summit Read More »
Latest News
As policy ecosystem threatens biotech, new treatments could drop by over 50% in 20 years
For decades, the United States has led the world in developing new medicines, turning scientific breakthroughs into treatments that save and improve lives. But
As policy ecosystem threatens biotech, new treatments could drop by over 50% in 20 years Read More »
Patient groups praise Virginia PDAB veto
Patient advocates are praising Virginia Gov. Abigail Spanberger’s May 19 veto of Prescription Drug Affordability Board (PDAB) legislation (HB 483 and SB 271), arguing
Patient groups praise Virginia PDAB veto Read More »
BIO 2026: Partnering meetings fill up for industry’s biggest gathering
The last time the BIO International Convention was in San Diego, in 2024, Ram May-Ron of the non-dilutive funding specialists FreeMind Group began discussing
BIO 2026: Partnering meetings fill up for industry’s biggest gathering Read More »
Section 232 tariff uncertainty remains high as onshoring plan deadline looms
Strengthening America’s biopharma manufacturing base and biotechnology leadership are goals both BIO and the Trump administration share. But as companies work to advance those
Section 232 tariff uncertainty remains high as onshoring plan deadline looms Read More »
Lawmakers warn against weakening IP for medicines in House hearing
Lawmakers defended strong IP protections as essential to biotech innovation that saves lives in a June 4 Congressional hearing that also considered the role
Lawmakers warn against weakening IP for medicines in House hearing Read More »
House hearing to examine bill balancing data privacy and R&D needs
Researchers utilize health data to inform medical breakthroughs, but patients need to know their personal information stays confidential. The current patchwork of state laws
House hearing to examine bill balancing data privacy and R&D needs Read More »
Cystic Fibrosis Awareness Month: A patient advocate’s story
Laura Bonnell always knew she wanted to be a news reporter. And throughout her entire career she was always on the hunt for answers.
Cystic Fibrosis Awareness Month: A patient advocate’s story Read More »
BIO supports and seeks refinements to FDA’s Plausible Mechanism Framework
Advances in individualized therapies targeting specific genetic conditions offer the promise of new treatments for rare diseases, but with so few patients, it can
BIO supports and seeks refinements to FDA’s Plausible Mechanism Framework Read More »
Exaggerated MFN cost-saving estimates imperil U.S. innovation and investment
The Administration’s Council of Economic Advisors (CEA) has released an analysis of savings expected from its “Most Favored Nation” deals with pharmaceutical manufacturers, but
Exaggerated MFN cost-saving estimates imperil U.S. innovation and investment Read More »